Foot-and-mouth disease: quarterly report
This quarterly report describes recent data for foot-and-mouth disease (FMD) outbreaks from April to June 2023. During this period, the World Reference Laboratory for Foot-and-Mouth Disease (WRLFMD) has reported test results for samples received from Bahrain, Ethiopia, Jordan, Nepal and Uganda. There have also been new sequence submissions from Oman (from ANSES on behalf of the Central Laboratory of Animal Health and from Sultan Qaboos University) and the Republic of Korea (APQA). The spread of the SAT2/XIV lineage that has emerged in the past six months to cause FMD outbreaks in countries in the Near East has been constantly monitored. This lineage originates in East Africa (Pool 4). Samples tested during this quarter from Bahrain and sequences provided from Oman (via ANSES, France) show that viruses from this lineage have been recently detected in a number of Gulf State countries supporting the idea that trade of live animals into the Persian Gulf from East Africa represents the most likely route by which the SAT2/XIV topotype has been introduced into the region. In Türkiye, SAT2/XIV outbreaks have been reported in Eastern and Central Anatolia, while in the Thrace region SAT2 vaccines (SAT2/Eri-98 from international suppliers and locally produced homologous vaccines from the ŞAP Institute) are being rapidly deployed to try to limit the potential impacts and spread of this lineage. Similarly, prophylactic vaccination using SAT2-specific vaccines is also being used in neighbouring countries (such as Armenia and Georgia). Elsewhere, new sequence data associated with FMD outbreaks has been received from the Republic of Korea, showing that these cases are due to the O/ME-SA/Ind-2001e lineage. This lineage is now widely distributed in Pool 1 (East/Southeast Asia) and has previously spread to cause outbreaks in the Russian Federation (2021), Kazakhstan (2022) and Indonesia (2022). There have also been new reports of cases due to serotype O (O/ME-SA/PanAsia-2ANT-10) in Palestine and O-EA-3 in North Africa (Libya).
Main Author: | |
---|---|
Format: | Booklet biblioteca |
Language: | English |
Published: |
FAO ;
2023
|
Online Access: | https://openknowledge.fao.org/handle/20.500.14283/cc7859en http://www.fao.org/3/cc7859en/cc7859en.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | This quarterly report describes recent data for foot-and-mouth disease (FMD) outbreaks from April to June 2023. During this period, the World Reference Laboratory for Foot-and-Mouth Disease (WRLFMD) has reported test results for samples received from Bahrain, Ethiopia, Jordan, Nepal and Uganda. There have also been new sequence submissions from Oman (from ANSES on behalf of the Central Laboratory of Animal Health and from Sultan Qaboos University) and the Republic of Korea (APQA).
The spread of the SAT2/XIV lineage that has emerged in the past six months to cause FMD outbreaks in countries in the Near East has been constantly monitored. This lineage originates in East Africa (Pool 4). Samples tested during this quarter from Bahrain and sequences provided from Oman (via ANSES, France) show that viruses from this lineage have been recently detected in a number of Gulf State countries supporting the idea that trade of live animals into the Persian Gulf from East Africa represents the most likely route by which the SAT2/XIV topotype has been introduced into the region. In Türkiye, SAT2/XIV outbreaks have been reported in Eastern and Central Anatolia, while in the Thrace region SAT2 vaccines (SAT2/Eri-98 from international suppliers and locally produced homologous vaccines from the ŞAP Institute) are being rapidly deployed to try to limit the potential impacts and spread of this lineage. Similarly, prophylactic vaccination using SAT2-specific vaccines is also being used in neighbouring countries (such as Armenia and Georgia).
Elsewhere, new sequence data associated with FMD outbreaks has been received from the Republic of Korea, showing that these cases are due to the O/ME-SA/Ind-2001e lineage. This lineage is now widely distributed in Pool 1 (East/Southeast Asia) and has previously spread to cause outbreaks in the Russian Federation (2021), Kazakhstan (2022) and Indonesia (2022). There have also been new reports of cases due to serotype O (O/ME-SA/PanAsia-2ANT-10) in Palestine and O-EA-3 in North Africa (Libya). |
---|